Investigating the Role of 17β-Estradiol on the Serotonergic System, Targeting Soy Isoflavones as a Strategy to Reduce Menopausal Depression: A Mechanistic Review

References

• Sassarini J. Depression in midlife women. Maturitas. 2016;94:149–54. doi:10.1016/j.maturitas.2016.09.004.
   PubMed Web of Science ®Google Scholar
• Schiller CE, Johnson SL, Abate AC, Schmidt PJ, Rubinow DR. Reproductive steroid regulation of mood and behaviour. Compr Physiol. 2018;6(3):1135–60. doi:10.1002/cphy.c150014.
   Web of Science ®Google Scholar
• Pestana-Oliveira N, Kalil B, Leite CM, Carolino ROG, Debarba LK, Elias LLK, Antunes-Rodrigues J, Anselmo-Franci JA. Effects of estrogen therapy on the serotonergic system in an animal model of perimenopause induced by 4-vinylcyclohexen diepoxide (VCD). eNeuro. 2018;5(1):ENEURO.0247-17.2017. doi:10.1523/ENEURO.0247-17.2017.
   Web of Science ®Google Scholar
• Soares CN. Depression and menopause: current knowledge and clinical recommendations for a critical window. Psychiatr Clin North Am. 2017;40(2):239–54. doi:10.1016/j.psc.2017.01.007.
   PubMed Web of Science ®Google Scholar
• Albert KM, Newhouse PA. Estrogen, stress, and depression: cognitive and biological interactions. Annu Rev Clin Psychol. 2019;15(1):399–423. doi:10.1146/annurev-clinpsy-050718-095557.
   PubMedGoogle Scholar
• Santoro N, Epperson NC, Mathews SB. Menopausal symptoms and their management. Endocrinol Metab Clin North Am. 2015;44(3):497–515. doi:10.1016/j.ecl.2015.05.001.
   PubMed Web of Science ®Google Scholar
• Rekkas PV, Wilson AA, Lee VWH, Yogalingam P, Sacher J, Rusjan P, Houle S, Stewart DE, Kolla NJ, Kish S, et al. Greater monoamine oxidase a binding in perimenopausal age as measured with carbon 11-labeled harmine positron emission tomography. JAMA Psychiatry. 2014;71(8):873–9. doi:10.1001/jamapsychiatry.2014.250.
   PubMed Web of Science ®Google Scholar
• Sacher J, Wilson AA, Houle S, Rusjan P, Hassan S, Bloomfield PM, Stewart DE, Meyer JH. Elevated brain monoamine oxidase A binding in the early postpartum period. Arch Gen Psychiatry. 2010;67(5):468–74. doi:10.1001/archgenpsychiatry.2010.32.
   PubMed Web of Science ®Google Scholar
• Gordon JL, Girdler SS, Meltzer-Brody SE, Stika CS, Thurston RC, Clark CT, Prairie BA, Moses-Kolko E, Joffe H, Wisner KL, et al. Ovarian hormone fluctuation, neurosteroids, and HPA axis dysregulation in perimenopausal depression: a novel heuristic model. Am J Psychiatry. 2015;172(3):227–36. doi:10.1176/appi.ajp.2014.14070918.
   PubMed Web of Science ®Google Scholar
• Georgakis MK, Thomopoulos TP, Diamantaras A-A, Kalogirou EI, Skalkidou A, Daskalopoulou SS, Petridou ET. Association of age at menopause and duration of reproductive period with depression after menopause: a systematic review and meta-analysis. JAMA Psychiatry. 2016;73(2):139–49. doi:10.1001/jamapsychiatry.2015.2653.
   PubMed Web of Science ®Google Scholar
• Del Río JP, Alliende MI, Molina N, Serrano FG, Molina, S, Vigil. P. Steroid hormones and their action in women’s brains: the importance of hormonal balance. Front Public Heal. 2018;6(May):1–15. doi:10.3389/fpubh.2018.00141.
   PubMedGoogle Scholar
• Hernández OT, Martínez L, Herrera JJ, Jiménez G. Role of estradiol in the expression of genes involved in serotonin neurotransmission: implications for female depression. Curr Neuropharmacol. 2018;17(5):459–71. doi:10.2174/1570159X16666180628165107.
   Web of Science ®Google Scholar
• Paredes S, Cantillo S, Candido KD, Knezevic NN. An association of serotonin with pain disorders and its modulation by estrogens. Int J Mol Sci. 2019;20(22):5729. doi:10.3390/ijms20225729.
   Web of Science ®Google Scholar
• Pottoo FH, Javed MN, Barkat MA, Alam MS, Nowshehri JA, Alshayban DM, Ansari MA. Estrogen and serotonin: complexity of Interactions and Implications for epileptic seizures and epileptogenesis. Curr Neuropharmacol. 2019;17(3):214–31. doi:10.2174/1570159X16666180628164432.
   PubMed Web of Science ®Google Scholar
• Davinelli S, Scapagnini G, Marzatico F, Nobile V, Ferrara N, Corbi G. Influence of equol and resveratrol supplementation on health-related quality of life in menopausal women: a randomized, placebo-controlled study. Maturitas. 2017;96(2017):77–83. doi:10.1016/j.maturitas.2016.11.016.
   PubMedGoogle Scholar
• Atteritano M, Mazzaferro S, Bitto A, Cannata ML, D’Anna R, Squadrito F, Macrì I, Frisina A, Frisina N, Bagnato G, et al. Genistein effects on quality of life and depression symptoms in osteopenic postmenopausal women: a 2-year randomized, double-blind, controlled study. Osteoporos Int. 2014;25(3):1123–9. doi:10.1007/s00198-013-2512-5.
   PubMed Web of Science ®Google Scholar
• Singhal S, Shullai W. Comparative study of gabapentin and isoflavone in menopausal vasomotor symptoms. J Midlife Health. 2016;7(3):132–9. doi:10.4103/0976-7800.191017.
   PubMedGoogle Scholar
• Křížová L, Dadáková K, Kašparovská J, Kašparovský T. Isoflavones. Molecules. 2019;24(6):1076. doi:10.3390/molecules24061076.
   PubMed Web of Science ®Google Scholar
• Setchell KDR, Cassidy A. Dietary isoflavones: biological effects and relevance to human health. J Nutr. 1999;129(Suppl. 3):758S–67S. doi:10.1093/jn/129.3.758S.
   PubMed Web of Science ®Google Scholar
• Clarkson TB, Utian WH, Barnes S, Gold EB, Basaria SS, Aso T, et al. The role of soy isoflavones in menopausal health: report of the North American Menopause Society/Wulf H. Menopause. 2011;18(7):732–53. doi:10.1097/gme.0b013e31821fc8e0.
   PubMedGoogle Scholar
• Mucci M, Carraro C, Mancino P, Monti M, Papadia L, Volpini G, et al. Soy isoflavones, lactobacilli, vitamin D3 and calcium. Obs Study Menopause Minerva Ginecol. 2006;58:212–21.
   Google Scholar
• Hanaway P. Form follows function: a functional medicine overview. Perm J. 2016;20(4):125–6. doi:10.7812/TPP/16-109.
   Google Scholar
• Sanchez RL, Reddy AP, Centeno ML, Henderson JA, Bethea CL. A second tryptophan hydroxylase isoform, TPH-2 mRNA, is increased by ovarian steroids in the raphe region of macaques. Brain Res Mol Brain Res. 2005;135(1-2):194–203. doi:10.1016/j.molbrainres.2004.12.011.
   PubMedGoogle Scholar
• Pandaranandaka J, Poonyachoti S, Kalandakanond-Thongsong S. Differential effects of exogenous and endogenous estrogen on anxiety as measured by elevated T-maze in relation to the serotonergic system. Behav Brain Res. 2009;198(1):142–8. doi:10.1016/j.bbr.2008.10.043.
   PubMed Web of Science ®Google Scholar
• Yang FZ, Wu Y, Zhang WG, Cai YY, Shi SX. Estradiol or fluoxetine alters depressive behavior and tryptophan hydroxylase in rat raphe. Neuroreport. 2010;21(4):309–12. doi:10.1097/WNR.0b013e3283377445.
   PubMed Web of Science ®Google Scholar
• Kunimura Y, Iwata K, Iijima N, Kobayashi M, Ozawa H. Effect of sex steroid hormones on the number of serotonergic neurons in rat dorsal raphe nucleus. Neurosci Lett. 2015;594:127–32. doi:10.1016/j.neulet.2015.03.060.
   PubMed Web of Science ®Google Scholar
• Benmansour S, Privratsky AA, Adeniji OS, Frazer A. Signaling mechanisms involved in the acute effects of estradiol on 5-HT clearance. Int J Neuropsychopharmacol. 2014;17(5):765–77. doi:10.1017/S146114571300165X.
   PubMed Web of Science ®Google Scholar
• Suzuki H, Barros RPA, Sugiyama N, Krishnan V, Yaden BC, Kim H-J, Warner M, Gustafsson J-Å. Involvement of estrogen receptor β in maintenance of serotonergic neurons of the dorsal raphe. Mol Psychiatry. 2013;18(6):674–80. doi:10.1038/mp.2012.62.
   PubMed Web of Science ®Google Scholar
• Donner NC, Handa RJ. Estrogen receptor beta regulates the expression of tryptophan- hydroxylase 2 mRNA within serotonergic neurons of the rat dorsal raphe nuclei. Neuroscience. 2009;163(2):705–18. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3624763/pdf/nihms412728.pdf doi:10.1016/j.neuroscience.2009.06.046.
   PubMed Web of Science ®Google Scholar
• Vargas KG, Milic J, Zaciragic A, Wen K-X, Jaspers L, Nano J, Dhana K, Bramer WM, Kraja B, van Beeck E, et al. The functions of estrogen receptor beta in the female brain: a systematic review. Maturitas. 2016;93:41–57. doi:10.1016/j.maturitas.2016.05.014.
   PubMed Web of Science ®Google Scholar
• Aggarwal M, Puri V, Puri S. Effects of estrogen on the serotonergic system and calcitonin generelated peptide in trigeminal ganglia of rats. Ann Neurosci. 2012;19(4):151–7. doi:10.5214/ans.0972.7531.190403.
   PubMedGoogle Scholar
• Benmansour S, Arroyo LD, Frazer A. Comparison of the antidepressant-like effects of estradiol and that of selective serotonin reuptake inhibitors in middle-aged ovariectomized rats. Front Aging Neurosci. 2016;8(Dec):311. doi:10.3389/fnagi.2016.00311.
   PubMedGoogle Scholar
• Charoenphandhu J, Teerapornpuntakit J, Nuntapornsak A, Krishnamra N, Charoenphandhu N. Anxiety-like behaviors and expression of SERT and TPH in the dorsal raphé of estrogen- and fluoxetine-treated ovariectomized rats. Pharmacol Biochem Behav. 2011;98(4):503–10. doi:10.1016/j.pbb.2011.02.023.
   PubMed Web of Science ®Google Scholar
• Sell SL, Craft RM, Seitz PK, Stutz SJ, Cunningham KA, Thomas ML. Estradiol-sertraline synergy in ovariectomized rats. Psychoneuroendocrinology. 2008;33(8):1051–60. doi:10.1016/j.psyneuen.2008.05.006.
   PubMed Web of Science ®Google Scholar
• Bertrand PP, Paranavitane UT, Chavez C, Gogos A, Jones M, Van Den Buuse M. The effect of low estrogen state on serotonin transporter function in mouse hippocampus: a behavioral and electrochemical study. Brain Res. 2005;1064(1–2):10–20. doi:10.1016/j.brainres.2005.10.018.
   PubMed Web of Science ®Google Scholar
• Sánchez MG, Estrada-Camarena E, Bélanger N, Morissette M, Di Paolo T. Estradiol modulation of cortical, striatal and raphe nucleus 5-HT 1A and 5-HT2A receptors of female hemiparkinsonian monkeys after long-term ovariectomy. Neuropharmacology. 2011;60(4):642–52. doi:10.1016/j.neuropharm.2010.11.024.
   PubMed Web of Science ®Google Scholar
• Le Saux M, Paolo D. T. Changes in 5-HT1A receptor binding and G-protein activation in the rat brain after estrogen treatment: comparison with tamoxifen and raloxifene. J Psychiatry Neurosci. 2005;30(2):110–7.
   PubMed Web of Science ®Google Scholar
• Moses-Kolko EL, Price JC, Shah N, Berga S, Sereika SM, Fisher PM, Coleman R, Becker C, Mason NS, Loucks T, et al. Age, sex, and reproductive hormone effects on brain serotonin-1A and serotonin-2A receptor binding in a healthy population. Neuropsychopharmacology. 2011;36(13):2729–40. doi:10.1038/npp.2011.163.
   PubMed Web of Science ®Google Scholar
• Kranz GS, Rami-Mark C, Kaufmann U, Baldinger P, Hahn A, Höflich A, Savli M, Stein P, Wadsak W, Mitterhauser M, et al. Effects of hormone replacement therapy on cerebral serotonin-1A receptor binding in postmenopausal women examined with [carbonyl-11C]WAY-100635. Psychoneuroendocrinology. 2014;45:1–10. doi:10.1016/j.psyneuen.2014.03.004.
   PubMed Web of Science ®Google Scholar
• Casini ML, Marelli G, Papaleo E, Ferrari A, D’Ambrosio F, Unfer V. Psychological assessment of the effects of treatment with phytoestrogens on postmenopausal women: a randomized, double-blind, crossover, placebo-controlled study. Fertil Steril. 2006;85(4):972–8. doi:10.1016/j.fertnstert.2005.09.048.
   PubMed Web of Science ®Google Scholar
• Hirose A, Terauchi M, Akiyoshi M, Owa Y, Kato K, Kubota T. Low-dose isoflavone aglycone alleviates psychological symptoms of menopause in Japanese women: a randomized, double-blind, placebo-controlled study. Arch Gynecol Obstet. 2016;293(3):609–15. doi:10.1007/s00404-015-3849-0.
   PubMed Web of Science ®Google Scholar
• Ishiwata N, Melby MK, Mizuno S, Watanabe S. New equol supplement for relieving menopausal symptoms: randomized, placebo-controlled trial of Japanese women. Menopause. 2009;16(1):141–8. doi:10.1097/gme.0b013e31818379fa.
   PubMed Web of Science ®Google Scholar
• Chedraui P, San Miguel G, Schwager G. The effect of soy-derived isoflavones over hot flushes, menopausal symptoms and mood in climacteric women with increased body mass index. Gynecol Endocrinol. 2011;27(5):307–13. doi:10.3109/09513590.2010.490614.
   PubMed Web of Science ®Google Scholar
• Nina Estrella RE, Landa AI, Lafuente JV, Gargiulo PA. Effects of antidepressants and soybean association in depressive menopausal women. Acta Pol Pharm - Drug Res. 2014;71(2):323–7.
   PubMed Web of Science ®Google Scholar
• Amato P, Young RL, Steinberg FM, Murray MJ, Lewis RD, Cramer MA, Barnes S, Ellis KJ, Shypailo RJ, Fraley JK, et al. Effect of soy isoflavone supplementation on menopausal quality of life. Menopause. 2013;20(4):443–7. doi:10.1097/gme.0b013e318275025e.
   PubMed Web of Science ®Google Scholar
• Duffy R, Wiseman H, File SE. Improved cognitive function in postmenopausal women after 12 weeks of consumption of a soya extract containing isoflavones. Pharmacol Biochem Behav. 2003;75(3):721–9. doi:10.1016/s0091-3057(03)00116-3.
   PubMed Web of Science ®Google Scholar
• File SE, Hartley DE, Elsabagh S, Duffy R, Wiseman H. Cognitive improvement after 6 weeks of soy supplements in postmenopausal women is limited to frontal lobe function. Menopause. 2005;12(2):193–201. doi:10.1097/00042192-200512020-00014.
   PubMed Web of Science ®Google Scholar
• Kok L, Kreijkamp-Kaspers S, Bots ML, Grobbee DE, Lampe JW, Van Der Schouw YT. A randomized controlled trial of the effects of soy protein containing isoflavones on quality of life in postmenopausal women. Menopause. 2005;12(1):56–62. doi:10.1097/00042192-200512010-00011.
   PubMed Web of Science ®Google Scholar
• Nikander E, Kilkkinen A, Metsä-Heikkilä M, Adlercreutz H, Pietinen P, Tiitinen A, et al. A randomized placebo-controlled crossover trial with phytoestrogens in treatment of menopause in breast cancer patients. Obstet Gynecol. 2003;101(6):1213–20. doi:10.1016/s0029-7844(03)00232-1.
   PubMed Web of Science ®Google Scholar
• Santos-Galduróz RF, Galduróz JCF, Facco RL, Hachul H, Tufik S. Effects of isoflavone on the learning and memory of women in menopause: a double-blind placebo-controlled study. Braz J Med Biol Res. 2010;43(11):1123–6. doi:10.1590/s0100-879x2010007500104.
   PubMed Web of Science ®Google Scholar
• Simpson EEA, Furlong ON, Parr HJ, Hodge SJ, Slevin MM, McSorley EM, McCormack JM, McConville C, Magee PJ. The effect of a randomized 12-week soy drink intervention on everyday mood in postmenopausal women. Menopause. 2019;26(8):867–73. doi:10.1097/GME.0000000000001322.
   PubMed Web of Science ®Google Scholar
• Hu P, Ma L, Wang Y-G, Ye F, Wang C, Zhou W-H, Zhao X. Genistein, a dietary soy isoflavone, exerts antidepressant-like effects in mice: involvement of serotonergic system. Neurochem Int. 2017;108:426–35. doi:10.1016/j.neuint.2017.06.002.
   PubMed Web of Science ®Google Scholar
• Richard A, Rohrmann S, Mohler-Kuo M, Rodgers S, Moffat R, Güth U, Eichholzer M. Urinary phytoestrogens and depression in perimenopausal US women: NHANES 2005-2008. J Affect Disord. 2014;156:200–5. doi:10.1016/j.jad.2013.12.029.
   PubMed Web of Science ®Google Scholar
• Perna S, Peroni G, Miccono A, Riva A, Morazzoni P, Allegrini P, Preda S, Baldiraghi V, Guido D, Rondanelli M, et al. Multidimensional effects of soy isoflavone by food or supplements in menopause women: a systematic review and bibliometric analysis. Nat Prod Commun. 2016;11(11):1733–40.
   PubMed Web of Science ®Google Scholar
• Shahmohammadi A, Ramezanpour N, Mahdavi Siuki M, Dizavandi F, Ghazanfarpour M, Rahmani Y, Tahajjodi R, Babakhanian M. The efficacy of herbal medicines on anxiety and depression in peri- and postmenopausal women: a systematic review and meta-analysis. Post Reprod Health. 2019;25(3):131–41. doi:10.1177/2053369119841166.
   PubMedGoogle Scholar
• Thomas AJ, Ismail R, Taylor-Swanson L, Cray L, Schnall JG, Mitchell ES, Woods NF. Effects of isoflavones and amino acid therapies for hot flashes and co-occurring symptoms during the menopausal transition and early post menopause: a systematic review. Maturitas. 2014;78(4):263–76. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3624763/pdf/nihms412728.pdf doi:10.1016/j.maturitas.2014.05.007.
   PubMed Web of Science ®Google Scholar
• Fattah A. Effect of phytoestrogen on depression and anxiety in menopausal women: a systematic review. J Menopausal Med. 2017;23(3):160–5. doi:10.6118/jmm.2017.23.3.160.
   PubMedGoogle Scholar
• Krebs EE, Ensrud KE, MacDonald R, Wilt TJ. Phytoestrogens for treatment of menopausal symptoms: a systematic review. Obstet Gynecol. 2004;104(4):824–36. doi:10.1097/01.AOG.0000140688.71638.d3.
   PubMed Web of Science ®Google Scholar
• Cheng P-F, Chen J-J, Zhou X-Y, Ren Y-F, Huang W, Zhou J-J, Xie P. Do soy isoflavones improve cognitive function in postmenopausal women? A meta-analysis. Menopause. 2015;22(2):198–206. doi:10.1097/GME.0000000000000290.
   PubMed Web of Science ®Google Scholar
• Rodríguez-Landa JF. Considerations of timing post-ovariectomy in mice and rats in studying anxiety- and depression-like behaviors associated with surgical menopause in women. Front Behav Neurosci. 2022;16(March):829274. doi:10.3389/fnbeh.2022.829274.
   PubMedGoogle Scholar
• Puga-Olguín A, Rodríguez-Landa JF, Rovirosa-Hernández MdJ, Germán-Ponciano LJ, Caba M, Meza E, Guillén-Ruiz G, Olmos-Vázquez OJ. Long-term ovariectomy increases anxiety- and despair-like behaviors associated with lower Fos immunoreactivity in the lateral septal nucleus in rats. Behav Brain Res. 2019;360(November 2018):185–95. doi:10.1016/j.bbr.2018.12.017.
   PubMedGoogle Scholar
• de Kruif M, Spijker AT, Molendijk ML. Depression during the perimenopause: a meta-analysis. J Affect Disord. 2016;206:174–80. doi:10.1016/j.jad.2016.07.040.
   PubMed Web of Science ®Google Scholar
• Weber MT, Maki PM, McDermott MP. Cognition and mood in perimenopause: a systematic review and meta-analysis. J Steroid Biochem Mol Biol. 2014;142 (July):90–8. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3624763/pdf/nihms412728.pdf doi:10.1016/j.jsbmb.2013.06.001.
   PubMedGoogle Scholar
• Elwood J, Murray E, Bell A, Sinclair M, Kernohan WG, Stockdale J. A systematic review investigating if genetic or epigenetic markers are associated with postnatal depression. J Affect Disord. 2019;253:51–62. doi:10.1016/j.jad.2019.04.059.
   PubMed Web of Science ®Google Scholar
• Maki PM, Kornstein SG, Joffe H, Bromberger JT, Freeman EW, Athappilly G, Bobo WV, Rubin LH, Koleva HK, Cohen LS, et al. Guidelines for the evaluation and treatment of perimenopausal depression: summary and recommendations. J Womens Health (Larchmt). 2019;28(2):117–34. doi:10.1089/jwh.2018.27099.mensocrec.
   PubMed Web of Science ®Google Scholar
• Vergne S, Titier K, Bernard V, Asselineau J, Durand M, Lamothe V, Potier M, Perez P, Demotes-Mainard J, Chantre P, et al. Bioavailability and urinary excretion of isoflavones in humans: effects of soy-based supplements formulation and equol production. J Pharm Biomed Anal. 2007;43(4):1488–94. doi:10.1016/j.jpba.2006.10.006.
   PubMed Web of Science ®Google Scholar
• Kumar D. From evidence-based medicine to genomic medicine. Genomic Med. 2007;1(3-4):95–104. doi:10.1007/s11568-007-9013-6.
   PubMedGoogle Scholar
• Barrow M, Bell L, Bell C. Transforming personalized nutrition practice. Nutr Rev. 2020;12(4):1046–1051. doi:10.1093/nutrit/nuaa012.
   Google Scholar
• Bereczki D. Personalized medicine: A competitor or an upgrade of evidence-based medicine? Per Med. 2012;9(2):211–21. doi:10.2217/pme.11.93.
   PubMed Web of Science ®Google Scholar
• Liu Y, Ma H, Yao J. A key target for cancer therpay. Onco Targets Ther. 2020;13:2183–91. doi:10.2147/OTT.S236532.
   PubMed Web of Science ®Google Scholar
• Boutas I, Kontogeorgi A, Dimitrakakis C, Kalantaridou SN. Soy isoflavones and breast cancer risk: a meta-analysis. In Vivo. 2022;36(2):556–62. doi:10.21873/invivo.12737.
   PubMed Web of Science ®Google Scholar